Cargando…

Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells

Genetic changes are difficult to reverse; thus, epigenetic aberrations, including changes in DNA methylation, histone modifications, and noncoding RNAs, with potential reversibility, have attracted attention as pharmaceutical targets. The current paradigm is that histone deacetylases (HDACs) regulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Sijia, Zhan, Lingjun, Li, Xue, Yang, Zhenhong, Luo, Yumin, Zhao, Haiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416716/ https://www.ncbi.nlm.nih.gov/pubmed/34512154 http://dx.doi.org/10.7150/ijbs.62001

Ejemplares similares

Nuclear mechanosensing controls MSC osteogenic potential through HDAC epigenetic remodeling
por: Killaars, Anouk R., et al.
Publicado: (2020)

TOPK Promotes Microglia/Macrophage Polarization towards M2 Phenotype via Inhibition of HDAC1 and HDAC2 Activity after Transient Cerebral Ischemia
por: Han, Ziping, et al.
Publicado: (2018)

Epigenetics of amphetamine-induced sensitization: HDAC5 expression and microRNA in neural remodeling
por: Liu, Philip K., et al.
Publicado: (2016)

Epigenetic Regulation of Oxidative Stress in Ischemic Stroke
por: Zhao, Haiping, et al.
Publicado: (2016)

Remodeling of retrotransposon elements during epigenetic induction of adult visual cortical plasticity by HDAC inhibitors
por: Lennartsson, Andreas, et al.
Publicado: (2015)

Epigenetic mechanisms of Immune remodeling in sepsis: targeting histone modification
por: Wu, Dan, et al.
Publicado: (2023)

Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
por: Claveria-Cabello, Alex, et al.
Publicado: (2020)

Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting
por: Nevi, Lorenzo, et al.
Publicado: (2023)

Effects of three flavonoids from an ancient traditional Chinese medicine Radix puerariae on geriatric diseases
por: Zhang, Sijia, et al.
Publicado: (2018)

Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2018)

Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation
por: Cini, Elena, et al.
Publicado: (2018)

Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer
por: Li, Yuxin, et al.
Publicado: (2020)

HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
por: Hull, Elizabeth E., et al.
Publicado: (2016)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021)

Therapeutic Potential and Cellular Mechanisms of Panax Notoginseng on Prevention of Aging and Cell Senescence-Associated Diseases
por: Zhao, Haiping, et al.
Publicado: (2017)

Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2019)

Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53
por: Mrakovcic, Maria, et al.
Publicado: (2018)

Epigenetics in Brain Tumors: HDACs Take Center Stage
por: Eyüpoglu, Ilker Y., et al.
Publicado: (2016)

Short communication: TNF-α and IGF-1 regulates epigenetic mechanisms of HDAC2 and HDAC10
por: Jiang, Wanlin, et al.
Publicado: (2022)

MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti‐COVID‐19 Therapeutics
por: Teodori, Laura, et al.
Publicado: (2020)

Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
por: Haydn, Tinka, et al.
Publicado: (2017)

Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC
por: Schade, Amy E., et al.
Publicado: (2023)

HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction
por: Zhu, Chenxi, et al.
Publicado: (2023)

Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
por: Tien, Feng-Ming, et al.
Publicado: (2023)

Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke
por: Zhao, Haiping, et al.
Publicado: (2020)

The Incremental Prognostic Value of Hepatocyte Growth Factor in First-Ever Acute Ischemic Stroke: An Early Link Between Growth Factor and Interleukins
por: Li, Fangfang, et al.
Publicado: (2021)

Targeting HDACs: A Promising Therapy for Alzheimer's Disease
por: Xu, Ke, et al.
Publicado: (2011)

Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
por: Naldi, Ilaria, et al.
Publicado: (2014)

Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure
por: Evans, Levi W., et al.
Publicado: (2018)

Targeting inducible epigenetic reprogramming pathways in chronic airway remodeling
por: Brasier, Allan R, et al.
Publicado: (2019)

Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition
por: Bertels, Zachariah, et al.
Publicado: (2021)

Proteomics Analysis of Human Obesity Reveals the Epigenetic Factor HDAC4 as a Potential Target for Obesity
por: Abu-Farha, Mohamed, et al.
Publicado: (2013)

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
por: Mayr, Christian, et al.
Publicado: (2021)

The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer
por: Huang, Rui, et al.
Publicado: (2015)

Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses
por: Wachowska, Malgorzata, et al.
Publicado: (2014)

EGCG prevents pressure overload-induced myocardial remodeling by downregulating overexpression of HDAC5 in mice
por: Han, Xiao, et al.
Publicado: (2022)

HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases
por: Shanmugam, Geetha, et al.
Publicado: (2021)

Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma
por: Fan, Yuxiang, et al.
Publicado: (2021)

Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites
por: Bougdour, Alexandre, et al.
Publicado: (2009)

HDAC mediated suppression of histone turnover promotes epigenetic stability of heterochromatin
por: Aygün, Ozan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7l0npbrbl77vr9rr93mvf1b5j9